BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 30791784)

  • 1. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
    Arias Á; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.
    Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):669-85. PubMed ID: 24742298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic esophagitis: an immune-mediated esophageal disease.
    Weinbrand-Goichberg J; Segal I; Ovadia A; Levine A; Dalal I
    Immunol Res; 2013 Jul; 56(2-3):249-60. PubMed ID: 23579771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
    Doyle AD; Masuda MY; Kita H; Wright BL
    Front Immunol; 2020; 11():603295. PubMed ID: 33335531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
    Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
    J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
    Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
    PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis.
    Cho JY; Rosenthal P; Miller M; Pham A; Aceves S; Sakuda S; Broide DH
    Int Immunopharmacol; 2014 Jan; 18(1):35-42. PubMed ID: 24239745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.
    Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU
    Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.
    Manresa MC; Chiang AWT; Kurten RC; Dohil R; Brickner H; Dohil L; Herro R; Akuthota P; Lewis NE; Croft M; Aceves SS
    Gastroenterology; 2020 Nov; 159(5):1778-1792.e13. PubMed ID: 32712105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue remodeling in eosinophilic esophagitis.
    Cheng E; Souza RF; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic esophagitis: an autoimmune esophageal disorder.
    Malhotra N; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):335-40. PubMed ID: 25499460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
    de Rooij WE; Dellon ES; Parker CE; Feagan BG; Jairath V; Ma C; Bredenoord AJ
    Drugs; 2019 Sep; 79(13):1419-1434. PubMed ID: 31352605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis.
    Noti M; Wojno ED; Kim BS; Siracusa MC; Giacomin PR; Nair MG; Benitez AJ; Ruymann KR; Muir AB; Hill DA; Chikwava KR; Moghaddam AE; Sattentau QJ; Alex A; Zhou C; Yearley JH; Menard-Katcher P; Kubo M; Obata-Ninomiya K; Karasuyama H; Comeau MR; Brown-Whitehorn T; de Waal Malefyt R; Sleiman PM; Hakonarson H; Cianferoni A; Falk GW; Wang ML; Spergel JM; Artis D
    Nat Med; 2013 Aug; 19(8):1005-13. PubMed ID: 23872715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning-based identification and characterization of mast cells in eosinophilic esophagitis.
    Zhang S; Caldwell JM; Rochman M; Collins MH; Rothenberg ME
    J Allergy Clin Immunol; 2024 May; 153(5):1381-1391.e6. PubMed ID: 38395083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort.
    Dunn JLM; Shoda T; Caldwell JM; Wen T; Aceves SS; Collins MH; Dellon ES; Falk GW; Leung J; Martin LJ; Menard-Katcher P; Rudman-Spergel AK; Spergel JM; Wechsler JB; Yang GY; Furuta GT; Rothenberg ME;
    J Allergy Clin Immunol; 2020 Jun; 145(6):1629-1640.e4. PubMed ID: 32197970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disodium cromoglycate treatment reduces T
    Silva FMCE; de Oliveira EE; Ambrósio MGE; Ayupe MC; de Souza VP; Menegati LM; Reis DRL; Machado MA; Macedo GC; Ferreira AP
    Int Immunopharmacol; 2020 Jun; 83():106422. PubMed ID: 32251959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity.
    Rochman M; Travers J; Abonia JP; Caldwell JM; Rothenberg ME
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.
    Otani IM; Anilkumar AA; Newbury RO; Bhagat M; Beppu LY; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2013 Jun; 131(6):1576-82. PubMed ID: 23623266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.